People: PerkinElmer Inc (PKI)

PKI on New York Consolidated

46.60USD
11 Jul 2014
Price Change (% chg)

$-0.09 (-0.19%)
Prev Close
$46.69
Open
$46.60
Day's High
$46.63
Day's Low
$46.27
Volume
326,621
Avg. Vol
783,767
52-wk High
$48.26
52-wk Low
$33.26

Search Stocks

Mullen, James 

Brief Biography

Mr. James C. Mullen is Independent Director of Perkinelmer Inc., since 2004. Mr. Mullen joined Patheon Inc. as Chief Executive Officer and member of the board in February 2011 after retiring from his position as President and Chief Executive Officer of Biogen Idec Inc. in 2010. Mr. Mullen joined Biogen, Inc. in 1989. He was named Chairman of the board of directors of Biogen in July 2002, after being named Chief Executive Officer in 2000. Mr. Mullen has also held the positions of President and Chief Operating Officer from 1999 to 2000; Vice President, International from 1996 to 1999; Vice President, Operations from 1992 to 1998; and Director, Facilities and Engineering from 1989 to 1992. In 2003, Mr. Mullen helped to lead the merger of Biogen, Inc. and IDEC Pharmaceuticals Corporation. He holds a Bachelor of Science degree in chemical engineering from Rensselaer Polytechnic Institute and a Master of Business Administration degree from Villanova University. In addition to serving on the board of Patheon Inc., he has served on the board of Biogen Idec Inc. during the past five years. Mr. Mullen is also a Trustee of The Rivers School.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Friel

6,511,990

Frank Wilson

1,708,530

Daniel Marshak

1,310,430

Joel Goldberg

1,443,160

John Letcher

1,035,460

James Corbett

1,016,920
As Of 28 Dec 2013
Search Stocks